MarketingRx roundup: AbbVie debuts Vraylar campaign for depression; Amylyx re-ups “Get Inked” for ALS effort
In December, AbbVie received a fourth indication for Vraylar as an add-on to antidepressants for the treatment of major depressive disorder – and now it’s launched an ad campaign in support.
The campaign includes a TV commercial with a bold purple and teal “V” that fills the screen, moving up from the bottom as a woman raises a garage door and talks about getting a “lift” for her antidepressant with the addition of Vraylar. According to an AbbVie spokesperson, the work launched in April and includes TV, online video, social and search media.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
